The $620 Million Footnote Behind DocuSign's "Cheap" Rebound

DocuSign set its next earnings date on the evening of August 13, and its stock did something unusual for a company that had just announced a reporting date: it climbed nearly 10% in after-hours trading to about $64, adding roughly $1 billion of market value in a single session. Two weeks later the shares still sit near $64. The move matters beyond the pop, because DocuSign — a company whose entire product is a document — has seen its story flip twice in a year, and the second flip looks to be running slightly ahead of the facts.

The first flip was panic. A year ago the market concluded that artificial intelligence would make electronic signatures obsolete. When OpenAI launched its contract-conversion product in late September 2025, DocuSign dropped nearly 12% in a day on competition fears. Two months earlier the company had cut its full-year billings outlook while shifting to an AI-based plan, and the stock fell 18% on that. By April of this year, after a Citigroup downgrade that halved its target, shares were down to roughly $42 — a long way from their 2021 peak near $324. The obituary wrote itself: a pandemic-era stock, a mature product, a target for every large language model.

The filings stopped cooperating with that obituary. In the first quarter of fiscal 2027 (the three months ended April 30, 2026), DocuSign reported revenue of $830 million, up 9% year over year, and non-GAAP operating income of $266 million, up 18%. Free cash flow was $289 million, a 35% margin, and the company generates roughly $1.1 billion of free cash a year on a market value near $12 billion. Its latest quarterly balance sheet shows no debt at all and roughly $1 billion of cash and investments. The business also shows quiet signs of health: customers spending more than $300,000 a year grew 12% year over year, the first double-digit increase in that cohort in three years. The balance-sheet version of DocuSign today is a cash machine, not a casualty.

Now read the earnings with the same care as the balance sheet, because that is where the story's second flip lives. In the first quarter, DocuSign reported adjusted earnings of $1.09 per share — and GAAP earnings of $0.40 per share. The 69-cent gap is the difference between two views of the same quarter:

Q1 fiscal 2027, three months ended April 30, 2026	Per share
GAAP net income	$0.40
Stock compensation alone	≈ $0.72
Other excluded items (intangibles, payroll taxes)	small
Adjusted (non-GAAP) earnings reported	$1.09

Stock compensation — paying employees partly in shares instead of cash, an expense that hits the income statement while no cash leaves the company — is the single biggest line in that reconciliation. It ran about $141 million in the quarter, roughly 72 cents per diluted share, enough by itself to cover the entire gap between the two earnings numbers. According to the fiscal 2026 annual report, stock compensation was about $622 million on $3.2 billion of revenue — nearly double the $309 million of GAAP net income, and roughly one out of every five dollars of sales.

This is where the buyback enters as the mirror of the footnote. DocuSign repurchased $869 million of its stock in fiscal 2026, then called the $318 million it bought back in the latest quarter the largest quarterly repurchase in company history, with about $2.4 billion of authorization remaining. Reduce the per-share arithmetic to its parts and you can see why the reported growth outruns the business: adjusted EPS rose 21% year over year on revenue growth of 9%, with help from a 2.5-point operating-margin gain and a diluted share count that fell about 8% in a year because of the repurchases. The buybacks are real, and the cash that funds them is real — but the same employee-compensation machine that the adjusted earnings number walls off is the issuance the buybacks are, in part, neutralizing.

That is disclosed, legal, and standard for mature software companies, and it is worth stating plainly: nothing here rises to a red flag, let alone an allegation. Cash conversion is strong, the balance sheet is clean, and management's follow-through on the buyback is visible in the filings. The honest objection is narrower and more useful: the "11x earnings" label that has circulated around this stock refers to an adjusted number that excludes roughly $620 million a year of stock compensation. On the company's actual profit under standard accounting, the stock trades near 39 times trailing earnings; on the adjusted figure, roughly 14 to 15 times at today's price. The price you are paying for the growth and the cash is up to about nine percent free-cash-flow yield — a real number, but a fair value quietly colored by a report that the company partly writes itself.

The rebound has already spent part of that goodwill. At about $64, DocuSign trades above the average analyst price target of roughly $57.50, with Wall Street's ratings tilted heavily to Hold. The bull case to the high-$100s requires revenue growth to re-accelerate, and the company's own guidance points the other way in the near term: second-quarter revenue is guided to about 8% growth at the midpoint, with the adjusted operating margin expected to step down from 32% to about 30%. The one genuine acceleration lever on the table is the AI-native Intelligent Agreement Management platform — at 12.6% of annual recurring revenue in the first quarter, with management targeting about 18% by fiscal year-end and more than $600 million of IAM in annual recurring revenue. That is the bet the stock now embodies: that AI, which the market feared would kill the signature, instead becomes the thing DocuSign sells more of.

Options traders are pricing an 11% swing either direction when DocuSign reports after the close on September 3 — the market itself is saying the cheap-versus-fair question is still open. Watch three numbers at that print rather than the headline EPS: whether annual recurring revenue actually accelerates toward the guided 8.5% range, how far IAM climbs toward 18% of that recurring revenue, and how much more stock the company buys back. The cash machine is real. The cheap multiple was, in part, a footnote. The difference between those two facts is the price of the next document.